top of page

[Collaborator's Work] Ribociclib plus Endocrine Therapy in MONALEESA-7: Updated OS Data

  • OOTR
  • Jun 24, 2022
  • 1 min read

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial


by Yen-Shen Lu, Seock Ah-Im, Louis Chow, and colleagues


Click the link below to read more:

Recent Posts

See All

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.

© 2025 by the Organisation for Oncology and Translational Research (OOTR)
Unit 2403, 24/F, Strand 50, 50 Bonham Strand, Sheung Wan, Hong Kong

bottom of page